Previous close | 0.5395 |
Open | 0.5400 |
Bid | 0.5251 x 1000 |
Ask | 0.5252 x 800 |
Day's range | 0.5229 - 0.5489 |
52-week range | 0.5010 - 2.7350 |
Volume | |
Avg. volume | 2,183,252 |
Market cap | 152.726M |
Beta (5Y monthly) | 1.00 |
PE ratio (TTM) | N/A |
EPS (TTM) | -2.3800 |
Earnings date | 01 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 2.08 |
Boston, April 25, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, announced that the company will participate in the Needham Technology, Media and Consumer Conference. Robert Shepardson, Amwell chief financial officer, will participate in a fireside chat on Tuesday, May 14, at a time to be determined, along with one-on-one investor meetings throughout the day. An audio webcast of the fireside chat will be available at investors.amwell.com. About Amwell Amwell i
Boston, April 17, 2024 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leader in hybrid care enablement, will report its first quarter 2024 operating results Wednesday, May 1. Following the distribution of the earnings release via wire services, the Amwell management team will host a live conference call and webcast at 5 p.m. ET to review the company's operating results and provide a general business update. The audio webcast can be accessed by visiting the Investors section of the company's website
Key Insights Significantly high institutional ownership implies American Well's stock price is sensitive to their...